Insider · CIK 0001061768

BAUPOST GROUP LLC/MA

Reports to the SEC for 10 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001061768

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-11-30	Veritiv CorpJ Other	10% Owner	JOther	−3.32M sh	$170.00	−$565M	0
2023-06-15	GTXGarrett Motion Inc.S Sale	10% Owner	SSale	−1.03M sh	$7.55	−$7.74M	26,570,589
2023-06-14	GTXGarrett Motion Inc.S Sale	10% Owner	SSale	−3.1M sh	$7.73	−$24M	27,595,589
2023-06-13	GTXGarrett Motion Inc.C Conversion	10% Owner	CConversion	+25.5M sh	—	—	31,195,589
2023-06-13	GTXGarrett Motion Inc.S Sale	10% Owner	SSale	−500K sh	$8.00	−$4M	30,695,589
2023-06-13	GTXGarrett Motion Inc. · Series A Cumulative Convertible Preferred StockC Conversion	10% Owner	CConversion	+25.5M sh	—	—	0
2023-06-08	GTXGarrett Motion Inc. · Series A Preferred StockS Sale	10% Owner	SSale	−17.5K sh	—	—	25,462,810
2023-06-08	GTXGarrett Motion Inc.S Sale	10% Owner	SSale	−500K sh	$8.20	−$4.1M	3,075,000
2021-12-10	GTXGarrett Motion Inc. · Series A Preferred StockS Sale	10% Owner	SSale	−1.83M sh	$8.20	−$15M	25,480,292
2021-09-14	Translate Bio, Inc.J Other	10% Owner	JOther	−18M sh	$38.00	−$686M	0
2021-05-11	GTXGarrett Motion Inc. · Series A Preferred StockS Sale	10% Owner	SSale	−762K sh	—	—	27,308,160
2021-05-07	GTXGarrett Motion Inc. · Series A Preferred StockS Sale	10% Owner	SSale	−381K sh	—	—	28,070,065
2021-04-30	GTXGarrett Motion Inc.J Other	10% Owner	JOther	−3.58M sh	—	—	0
2020-07-23	VSATVIASAT INCP Purchase	10% Owner	PPurchase	+2.56M sh	$39.11	+$100M	16,288,959
2020-06-26	Translate Bio, Inc.P Purchase	10% Owner	PPurchase	+500K sh	$22.00	+$11M	18,044,239
2019-05-31	Orexigen Therapeutics, Inc.0% Senior Secured Convertible Notes due 2020J Other	10% Owner	JOther	—	—	—	0
2019-05-31	Orexigen Therapeutics, Inc.Warrant Expiring 2026J Other	10% Owner	JOther	−100M sh	—	—	0
2019-05-31	Orexigen Therapeutics, Inc.Warrant Expiring 2020J Other	10% Owner	JOther	−5M sh	—	—	0
2018-12-12	KERYX BIOPHARMACEUTICALS INCD Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−65.4M sh	—	—	0
2018-12-11	KERYX BIOPHARMACEUTICALS INCA Award	Director, 10% Owner	AAward	+35.6M sh	$4.63	+$165M	61,374,013
2018-12-11	KERYX BIOPHARMACEUTICALS INCA Award	Director, 10% Owner	AAward	+4M sh	—	—	65,374,013
2018-12-11	KERYX BIOPHARMACEUTICALS INCZero Coupon Senior Convertible Notes due 2021M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	—	—	—	0
2018-10-31	Orexigen Therapeutics, Inc.S Sale	10% Owner	SSale	−896K sh	$0.01	−$8,963.39	0
2018-10-29	Orexigen Therapeutics, Inc.S Sale	10% Owner	SSale	−650K sh	$0.01	−$6,500	896,339
2018-10-25	Orexigen Therapeutics, Inc.S Sale	10% Owner	SSale	−653K sh	$0.01	−$6,525	1,546,339
2018-10-24	Orexigen Therapeutics, Inc.S Sale	10% Owner	SSale	−28K sh	$0.01	−$280	2,198,839
2018-05-08	KERYX BIOPHARMACEUTICALS INCZero Coupon Convertible Senior Notes due 2020D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	—	$125000000.00	—	0
2018-05-08	KERYX BIOPHARMACEUTICALS INCZero Coupon Senior Convertible Notes due 2021A Award	Director, 10% Owner	AAward	—	—	—	—
2018-04-13	Orexigen Therapeutics, Inc.0% Senior Secured Convertible Notes due 2020J Other	10% Owner	JOther	−16.5M sh	—	—	7,802,197
2014-08-05	IDENIX PHARMACEUTICALS INCJ Other	10% Owner	JOther	−53.3M sh	$24.50	−$1.31B	0
2014-01-31	IDENIX PHARMACEUTICALS INCP Purchase	10% Owner	PPurchase	+16.4M sh	$6.50	+$107M	53,331,109
2010-04-19	ABBOTT BIOTHERAPEUTICS CORPU Disposition from Tender	10% Owner	UDisposition from Tender	−1.5M sh	$27.00	−$40.5M	0
2010-04-08	ABBOTT BIOTHERAPEUTICS CORPS Sale	10% Owner	SSale	−500K sh	$26.96	−$13.5M	1,500,000
2010-03-16	ABBOTT BIOTHERAPEUTICS CORPS Sale	10% Owner	SSale	−1.51M sh	$27.00	−$40.7M	2,000,000
2009-12-24	RHI Entertainment, Inc.S Sale	10% Owner	SSale	−500K sh	$0.28	−$139K	0
2009-12-24	RHI Entertainment, Inc.S Sale	10% Owner	SSale	−1.83M sh	$0.28	−$511K	500,000
2009-12-24	RHI Entertainment, Inc.S Sale	10% Owner	SSale	−714K sh	$0.43	−$305K	2,329,851
2009-12-24	RHI Entertainment, Inc.S Sale	10% Owner	SSale	−1.86M sh	$0.42	−$776K	3,043,551
2009-09-04	ABBOTT BIOTHERAPEUTICS CORPS Sale	10% Owner	SSale	−150K sh	$15.39	−$2.31M	4,224,407
2009-09-04	ABBOTT BIOTHERAPEUTICS CORPS Sale	10% Owner	SSale	−100K sh	$15.40	−$1.54M	4,124,407
2009-09-04	ABBOTT BIOTHERAPEUTICS CORPS Sale	10% Owner	SSale	−10.2K sh	$15.50	−$158K	4,114,207
2009-09-04	ABBOTT BIOTHERAPEUTICS CORPS Sale	10% Owner	SSale	−27.9K sh	$15.49	−$432K	4,086,307
2009-09-04	ABBOTT BIOTHERAPEUTICS CORPS Sale	10% Owner	SSale	−579K sh	$15.43	−$8.94M	3,506,875
2009-03-30	RHI Entertainment, Inc.P Purchase	10% Owner	PPurchase	+373K sh	$1.19	+$444K	4,836,448
2009-03-30	RHI Entertainment, Inc.P Purchase	10% Owner	PPurchase	+64.1K sh	$1.19	+$76.3K	4,900,551
2009-02-04	RHI Entertainment, Inc.P Purchase	10% Owner	PPurchase	+170K sh	$4.28	+$728K	4,248,334
2009-02-04	RHI Entertainment, Inc.P Purchase	10% Owner	PPurchase	+215K sh	$4.28	+$921K	4,463,534
2009-01-14	RHI Entertainment, Inc.P Purchase	10% Owner	PPurchase	+417K sh	$4.25	+$1.77M	4,078,332

Recent filings

Accepted (ET)
Dec 64
KLARMAN SETH A0001140361-23-056518
SEC(opens sec.gov)
Jun 154
KLARMAN SETH A0001140361-23-030150
SEC(opens sec.gov)
Jun 124
KLARMAN SETH A0001140361-23-029345
SEC(opens sec.gov)
Dec 144
KLARMAN SETH A0001567619-21-022047
SEC(opens sec.gov)
Sep 164/A
KLARMAN SETH A0001567619-21-017206
SEC(opens sec.gov)
May 134
KLARMAN SETH A0001567619-21-009872
SEC(opens sec.gov)
May 114
KLARMAN SETH A0001567619-21-009558
SEC(opens sec.gov)
May 44
KLARMAN SETH A0001567619-21-009012
SEC(opens sec.gov)
Jul 274
Baupost Group GP, L.L.C.0001567619-20-013767
SEC(opens sec.gov)
Jun 304
BAUPOST GROUP LLC/MA0001567619-20-012703
SEC(opens sec.gov)
Jun 44
BAUPOST GROUP LLC/MA0001567619-19-012688
SEC(opens sec.gov)
Dec 134
BAUPOST GROUP LLC/MA0001567619-18-007897
SEC(opens sec.gov)

Companies

Address

10 ST JAMES AVE SUITE 1700

BOSTON, MA, 02116